img

Global Poly-Myalgia Rheumatica Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Poly-Myalgia Rheumatica Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rheumatic polymyalgia (PMR) is a painful disease unrelated to other definitely diagnosed rheumatic diseases, infections and tumors. It is common in the elderly, accompanied by rapid erythrocyte sedimentation rate. PMR is a clinical syndrome characterized by limb and proximal trunk muscle pain, which is sensitive to low-dose hormone therapy. It often shows pain and stiffness in 2 or more parts of the neck, scapular band and pelvic band muscles, lasting for 30 minutes or more, not less than 1 month, and older than 50 years.

报错
笔记
Poly-Myalgia Rheumatica Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Poly-Myalgia Rheumatica Treatment market is projected to reach US$ 287.7 million in 2029, increasing from US$ 193 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Demand from Hospital and Specialist Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Poly-Myalgia Rheumatica Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mylan N.V
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
AstraZeneca
Johnson & Johnson Private Limited
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
PuraCap® Pharmaceutical LLC
Glenmark Pharmaceuticals Limited
Segment by Type
Glucocorticoid
NSAIDs

Segment by Application


Hospital
Specialist Clinic

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Poly-Myalgia Rheumatica Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Poly-Myalgia Rheumatica Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Poly-Myalgia Rheumatica Treatment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Poly-Myalgia Rheumatica Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Poly-Myalgia Rheumatica Treatment introduction, etc. Poly-Myalgia Rheumatica Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Poly-Myalgia Rheumatica Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Poly-Myalgia Rheumatica Treatment Market Overview
1.1 Poly-Myalgia Rheumatica Treatment Product Overview
1.2 Poly-Myalgia Rheumatica Treatment Market Segment by Type
1.2.1 Glucocorticoid
1.2.2 NSAIDs
1.3 Global Poly-Myalgia Rheumatica Treatment Market Size by Type
1.3.1 Global Poly-Myalgia Rheumatica Treatment Market Size Overview by Type (2018-2029)
1.3.2 Global Poly-Myalgia Rheumatica Treatment Historic Market Size Review by Type (2018-2024)
1.3.3 Global Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poly-Myalgia Rheumatica Treatment Sales Breakdown by Type (2018-2024)
1.4.2 Europe Poly-Myalgia Rheumatica Treatment Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Poly-Myalgia Rheumatica Treatment Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Breakdown by Type (2018-2024)
2 Global Poly-Myalgia Rheumatica Treatment Market Competition by Company
2.1 Global Top Players by Poly-Myalgia Rheumatica Treatment Sales (2018-2024)
2.2 Global Top Players by Poly-Myalgia Rheumatica Treatment Revenue (2018-2024)
2.3 Global Top Players by Poly-Myalgia Rheumatica Treatment Price (2018-2024)
2.4 Global Top Manufacturers Poly-Myalgia Rheumatica Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poly-Myalgia Rheumatica Treatment Market Competitive Situation and Trends
2.5.1 Poly-Myalgia Rheumatica Treatment Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Poly-Myalgia Rheumatica Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poly-Myalgia Rheumatica Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Poly-Myalgia Rheumatica Treatment Market
2.8 Key Manufacturers Poly-Myalgia Rheumatica Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poly-Myalgia Rheumatica Treatment Status and Outlook by Region
3.1 Global Poly-Myalgia Rheumatica Treatment Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Poly-Myalgia Rheumatica Treatment Historic Market Size by Region
3.2.1 Global Poly-Myalgia Rheumatica Treatment Sales in Volume by Region (2018-2024)
3.2.2 Global Poly-Myalgia Rheumatica Treatment Sales in Value by Region (2018-2024)
3.2.3 Global Poly-Myalgia Rheumatica Treatment Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Region
3.3.1 Global Poly-Myalgia Rheumatica Treatment Sales in Volume by Region (2024-2029)
3.3.2 Global Poly-Myalgia Rheumatica Treatment Sales in Value by Region (2024-2029)
3.3.3 Global Poly-Myalgia Rheumatica Treatment Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Poly-Myalgia Rheumatica Treatment by Application
4.1 Poly-Myalgia Rheumatica Treatment Market Segment by Application
4.1.1 Hospital
4.1.2 Specialist Clinic
4.2 Global Poly-Myalgia Rheumatica Treatment Market Size by Application
4.2.1 Global Poly-Myalgia Rheumatica Treatment Market Size Overview by Application (2018-2029)
4.2.2 Global Poly-Myalgia Rheumatica Treatment Historic Market Size Review by Application (2018-2024)
4.2.3 Global Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poly-Myalgia Rheumatica Treatment Sales Breakdown by Application (2018-2024)
4.3.2 Europe Poly-Myalgia Rheumatica Treatment Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Poly-Myalgia Rheumatica Treatment Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Breakdown by Application (2018-2024)
5 North America Poly-Myalgia Rheumatica Treatment by Country
5.1 North America Poly-Myalgia Rheumatica Treatment Historic Market Size by Country
5.1.1 North America Poly-Myalgia Rheumatica Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2018-2024)
5.1.3 North America Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2018-2024)
5.2 North America Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Country
5.2.1 North America Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2024-2029)
5.2.2 North America Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2024-2029)
6 Europe Poly-Myalgia Rheumatica Treatment by Country
6.1 Europe Poly-Myalgia Rheumatica Treatment Historic Market Size by Country
6.1.1 Europe Poly-Myalgia Rheumatica Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2018-2024)
6.1.3 Europe Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2018-2024)
6.2 Europe Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Country
6.2.1 Europe Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2024-2029)
6.2.2 Europe Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2024-2029)
7 Asia-Pacific Poly-Myalgia Rheumatica Treatment by Region
7.1 Asia-Pacific Poly-Myalgia Rheumatica Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Poly-Myalgia Rheumatica Treatment Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales in Value by Region (2024-2029)
8 Latin America Poly-Myalgia Rheumatica Treatment by Country
8.1 Latin America Poly-Myalgia Rheumatica Treatment Historic Market Size by Country
8.1.1 Latin America Poly-Myalgia Rheumatica Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2018-2024)
8.1.3 Latin America Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2018-2024)
8.2 Latin America Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Country
8.2.1 Latin America Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2024-2029)
8.2.2 Latin America Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2024-2029)
9 Middle East and Africa Poly-Myalgia Rheumatica Treatment by Country
9.1 Middle East and Africa Poly-Myalgia Rheumatica Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Poly-Myalgia Rheumatica Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Poly-Myalgia Rheumatica Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mylan N.V
10.1.1 Mylan N.V Company Information
10.1.2 Mylan N.V Introduction and Business Overview
10.1.3 Mylan N.V Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Mylan N.V Poly-Myalgia Rheumatica Treatment Products Offered
10.1.5 Mylan N.V Recent Development
10.2 Teva Pharmaceutical Industries Ltd
10.2.1 Teva Pharmaceutical Industries Ltd Company Information
10.2.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.2.3 Teva Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Products Offered
10.2.5 Teva Pharmaceutical Industries Ltd Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Poly-Myalgia Rheumatica Treatment Products Offered
10.3.5 Sanofi Recent Development
10.4 Pfizer Inc
10.4.1 Pfizer Inc Company Information
10.4.2 Pfizer Inc Introduction and Business Overview
10.4.3 Pfizer Inc Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Inc Poly-Myalgia Rheumatica Treatment Products Offered
10.4.5 Pfizer Inc Recent Development
10.5 GSK plc
10.5.1 GSK plc Company Information
10.5.2 GSK plc Introduction and Business Overview
10.5.3 GSK plc Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GSK plc Poly-Myalgia Rheumatica Treatment Products Offered
10.5.5 GSK plc Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis AG Poly-Myalgia Rheumatica Treatment Products Offered
10.6.5 Novartis AG Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information
10.7.2 AstraZeneca Introduction and Business Overview
10.7.3 AstraZeneca Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.7.4 AstraZeneca Poly-Myalgia Rheumatica Treatment Products Offered
10.7.5 AstraZeneca Recent Development
10.8 Johnson & Johnson Private Limited
10.8.1 Johnson & Johnson Private Limited Company Information
10.8.2 Johnson & Johnson Private Limited Introduction and Business Overview
10.8.3 Johnson & Johnson Private Limited Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Johnson & Johnson Private Limited Poly-Myalgia Rheumatica Treatment Products Offered
10.8.5 Johnson & Johnson Private Limited Recent Development
10.9 Sun Pharmaceutical Industries Ltd
10.9.1 Sun Pharmaceutical Industries Ltd Company Information
10.9.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.9.3 Sun Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sun Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Products Offered
10.9.5 Sun Pharmaceutical Industries Ltd Recent Development
10.10 Merck & Co., Inc
10.10.1 Merck & Co., Inc Company Information
10.10.2 Merck & Co., Inc Introduction and Business Overview
10.10.3 Merck & Co., Inc Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Merck & Co., Inc Poly-Myalgia Rheumatica Treatment Products Offered
10.10.5 Merck & Co., Inc Recent Development
10.11 Lilly
10.11.1 Lilly Company Information
10.11.2 Lilly Introduction and Business Overview
10.11.3 Lilly Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lilly Poly-Myalgia Rheumatica Treatment Products Offered
10.11.5 Lilly Recent Development
10.12 Amgen Inc
10.12.1 Amgen Inc Company Information
10.12.2 Amgen Inc Introduction and Business Overview
10.12.3 Amgen Inc Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Amgen Inc Poly-Myalgia Rheumatica Treatment Products Offered
10.12.5 Amgen Inc Recent Development
10.13 PuraCap® Pharmaceutical LLC
10.13.1 PuraCap® Pharmaceutical LLC Company Information
10.13.2 PuraCap® Pharmaceutical LLC Introduction and Business Overview
10.13.3 PuraCap® Pharmaceutical LLC Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.13.4 PuraCap® Pharmaceutical LLC Poly-Myalgia Rheumatica Treatment Products Offered
10.13.5 PuraCap® Pharmaceutical LLC Recent Development
10.14 Glenmark Pharmaceuticals Limited
10.14.1 Glenmark Pharmaceuticals Limited Company Information
10.14.2 Glenmark Pharmaceuticals Limited Introduction and Business Overview
10.14.3 Glenmark Pharmaceuticals Limited Poly-Myalgia Rheumatica Treatment Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Glenmark Pharmaceuticals Limited Poly-Myalgia Rheumatica Treatment Products Offered
10.14.5 Glenmark Pharmaceuticals Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poly-Myalgia Rheumatica Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poly-Myalgia Rheumatica Treatment Industrial Chain Analysis
11.4 Poly-Myalgia Rheumatica Treatment Market Dynamics
11.4.1 Poly-Myalgia Rheumatica Treatment Industry Trends
11.4.2 Poly-Myalgia Rheumatica Treatment Market Drivers
11.4.3 Poly-Myalgia Rheumatica Treatment Market Challenges
11.4.4 Poly-Myalgia Rheumatica Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poly-Myalgia Rheumatica Treatment Distributors
12.3 Poly-Myalgia Rheumatica Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Glucocorticoid
Table 2. Major Company of NSAIDs
Table 3. Global Poly-Myalgia Rheumatica Treatment Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (K Units)
Table 5. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US& Million)
Table 7. Global Poly-Myalgia Rheumatica Treatment Market Share in Value by Type (2018-2024)
Table 8. Global Poly-Myalgia Rheumatica Treatment Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Poly-Myalgia Rheumatica Treatment Sales by Type (2024-2029) & (K Units)
Table 10. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Poly-Myalgia Rheumatica Treatment Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type (2024-2029)
Table 13. Global Poly-Myalgia Rheumatica Treatment Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (K Units)
Table 15. North America Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Poly-Myalgia Rheumatica Treatment Sales (K Units) by Type (2018-2024)
Table 17. Europe Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Poly-Myalgia Rheumatica Treatment Sales (K Units) by Type (2018-2024)
Table 21. Latin America Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Poly-Myalgia Rheumatica Treatment Sales by Company (2018-2024) & (K Units)
Table 25. Global Poly-Myalgia Rheumatica Treatment Sales Share by Company (2018-2024)
Table 26. Global Poly-Myalgia Rheumatica Treatment Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Poly-Myalgia Rheumatica Treatment Revenue Share by Company (2018-2024)
Table 28. Global Market Poly-Myalgia Rheumatica Treatment Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Poly-Myalgia Rheumatica Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Poly-Myalgia Rheumatica Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poly-Myalgia Rheumatica Treatment as of 2022)
Table 32. Date of Key Manufacturers Enter into Poly-Myalgia Rheumatica Treatment Market
Table 33. Key Manufacturers Poly-Myalgia Rheumatica Treatment Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Poly-Myalgia Rheumatica Treatment Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Poly-Myalgia Rheumatica Treatment Sales by Region (2018-2024) & (K Units)
Table 37. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Poly-Myalgia Rheumatica Treatment Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Region (2018-2024)
Table 40. Global Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Poly-Myalgia Rheumatica Treatment Sales by Region (2024-2029) & (K Units)
Table 42. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Poly-Myalgia Rheumatica Treatment Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Region (2024-2029)
Table 45. Global Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Poly-Myalgia Rheumatica Treatment Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (K Units)
Table 48. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application (2018-2024)
Table 51. Global Poly-Myalgia Rheumatica Treatment Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Poly-Myalgia Rheumatica Treatment Sales by Application (2024-2029) & (K Units)
Table 53. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Poly-Myalgia Rheumatica Treatment Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application (2024-2029)
Table 56. Global Poly-Myalgia Rheumatica Treatment Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) (K Units)
Table 58. North America Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) (K Units)
Table 60. Europe Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) (K Units)
Table 64. Latin America Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (K Units)
Table 68. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2018-2024)
Table 71. North America Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (K Units)
Table 72. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (K Units)
Table 76. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (K Units)
Table 80. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Country (2024-2029)
Table 107. Mylan N.V Company Information
Table 108. Mylan N.V Introduction and Business Overview
Table 109. Mylan N.V Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Mylan N.V Poly-Myalgia Rheumatica Treatment Product
Table 111. Mylan N.V Recent Development
Table 112. Teva Pharmaceutical Industries Ltd Company Information
Table 113. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 114. Teva Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Teva Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Product
Table 116. Teva Pharmaceutical Industries Ltd Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Poly-Myalgia Rheumatica Treatment Product
Table 121. Sanofi Recent Development
Table 122. Pfizer Inc Company Information
Table 123. Pfizer Inc Introduction and Business Overview
Table 124. Pfizer Inc Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Inc Poly-Myalgia Rheumatica Treatment Product
Table 126. Pfizer Inc Recent Development
Table 127. GSK plc Company Information
Table 128. GSK plc Introduction and Business Overview
Table 129. GSK plc Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. GSK plc Poly-Myalgia Rheumatica Treatment Product
Table 131. GSK plc Recent Development
Table 132. Novartis AG Company Information
Table 133. Novartis AG Introduction and Business Overview
Table 134. Novartis AG Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Novartis AG Poly-Myalgia Rheumatica Treatment Product
Table 136. Novartis AG Recent Development
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Introduction and Business Overview
Table 139. AstraZeneca Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. AstraZeneca Poly-Myalgia Rheumatica Treatment Product
Table 141. AstraZeneca Recent Development
Table 142. Johnson & Johnson Private Limited Company Information
Table 143. Johnson & Johnson Private Limited Introduction and Business Overview
Table 144. Johnson & Johnson Private Limited Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Johnson & Johnson Private Limited Poly-Myalgia Rheumatica Treatment Product
Table 146. Johnson & Johnson Private Limited Recent Development
Table 147. Sun Pharmaceutical Industries Ltd Company Information
Table 148. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 149. Sun Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Sun Pharmaceutical Industries Ltd Poly-Myalgia Rheumatica Treatment Product
Table 151. Sun Pharmaceutical Industries Ltd Recent Development
Table 152. Merck & Co., Inc Company Information
Table 153. Merck & Co., Inc Introduction and Business Overview
Table 154. Merck & Co., Inc Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Merck & Co., Inc Poly-Myalgia Rheumatica Treatment Product
Table 156. Merck & Co., Inc Recent Development
Table 157. Lilly Company Information
Table 158. Lilly Introduction and Business Overview
Table 159. Lilly Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Lilly Poly-Myalgia Rheumatica Treatment Product
Table 161. Lilly Recent Development
Table 162. Amgen Inc Company Information
Table 163. Amgen Inc Introduction and Business Overview
Table 164. Amgen Inc Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Amgen Inc Poly-Myalgia Rheumatica Treatment Product
Table 166. Amgen Inc Recent Development
Table 167. PuraCap® Pharmaceutical LLC Company Information
Table 168. PuraCap® Pharmaceutical LLC Introduction and Business Overview
Table 169. PuraCap® Pharmaceutical LLC Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. PuraCap® Pharmaceutical LLC Poly-Myalgia Rheumatica Treatment Product
Table 171. PuraCap® Pharmaceutical LLC Recent Development
Table 172. Glenmark Pharmaceuticals Limited Company Information
Table 173. Glenmark Pharmaceuticals Limited Introduction and Business Overview
Table 174. Glenmark Pharmaceuticals Limited Poly-Myalgia Rheumatica Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Glenmark Pharmaceuticals Limited Poly-Myalgia Rheumatica Treatment Product
Table 176. Glenmark Pharmaceuticals Limited Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Poly-Myalgia Rheumatica Treatment Market Trends
Table 180. Poly-Myalgia Rheumatica Treatment Market Drivers
Table 181. Poly-Myalgia Rheumatica Treatment Market Challenges
Table 182. Poly-Myalgia Rheumatica Treatment Market Restraints
Table 183. Poly-Myalgia Rheumatica Treatment Distributors List
Table 184. Poly-Myalgia Rheumatica Treatment Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Poly-Myalgia Rheumatica Treatment Product Picture
Figure 2. Global Poly-Myalgia Rheumatica Treatment Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Poly-Myalgia Rheumatica Treatment Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Poly-Myalgia Rheumatica Treatment Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Glucocorticoid
Figure 6. Global Glucocorticoid Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of NSAIDs
Figure 8. Global NSAIDs Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Poly-Myalgia Rheumatica Treatment Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Poly-Myalgia Rheumatica Treatment Sales Market Share by Type in 2022 & 2029
Figure 11. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type in 2022
Figure 12. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type in 2022
Figure 13. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type in 2022
Figure 14. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type in 2022
Figure 17. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Poly-Myalgia Rheumatica Treatment Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Poly-Myalgia Rheumatica Treatment Revenue in 2022
Figure 23. Poly-Myalgia Rheumatica Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Specialist Clinic
Figure 27. Global Specialist Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Poly-Myalgia Rheumatica Treatment Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Poly-Myalgia Rheumatica Treatment Sales Market Share by Application in 2022 & 2029
Figure 30. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application in 2022
Figure 31. North America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application in 2022
Figure 32. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application in 2022
Figure 33. Europe Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application in 2022
Figure 36. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Poly-Myalgia Rheumatica Treatment Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Poly-Myalgia Rheumatica Treatment Manufacturing Cost Structure
Figure 41. Poly-Myalgia Rheumatica Treatment Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed